Reece Goiffon, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Biliary Tract | 2 | 2023 | 132 | 0.840 |
Why?
|
Luminescent Measurements | 1 | 2015 | 376 | 0.430 |
Why?
|
Polyps | 2 | 2024 | 197 | 0.400 |
Why?
|
Peroxidase | 1 | 2015 | 600 | 0.400 |
Why?
|
Liver Transplantation | 1 | 2023 | 2203 | 0.390 |
Why?
|
Kidney Function Tests | 1 | 2009 | 665 | 0.280 |
Why?
|
Spectrometry, Fluorescence | 1 | 2009 | 683 | 0.280 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11079 | 0.270 |
Why?
|
Proteinuria | 1 | 2009 | 638 | 0.260 |
Why?
|
Microscopy, Fluorescence | 2 | 2009 | 2663 | 0.240 |
Why?
|
Whole Body Imaging | 2 | 2021 | 278 | 0.230 |
Why?
|
Tomography, X-Ray Computed | 5 | 2024 | 20139 | 0.230 |
Why?
|
Solitary Fibrous Tumors | 1 | 2023 | 64 | 0.210 |
Why?
|
Urinary Bladder | 1 | 2009 | 1168 | 0.210 |
Why?
|
Hyperhidrosis | 1 | 2022 | 34 | 0.200 |
Why?
|
Hepatic Artery | 1 | 2023 | 230 | 0.200 |
Why?
|
Gallbladder Neoplasms | 1 | 2023 | 189 | 0.200 |
Why?
|
Mediastinal Diseases | 1 | 2022 | 91 | 0.200 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6748 | 0.190 |
Why?
|
Cholangitis, Sclerosing | 1 | 2022 | 177 | 0.180 |
Why?
|
Hemochromatosis | 1 | 2021 | 170 | 0.180 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 327 | 0.170 |
Why?
|
Rotation | 1 | 2021 | 511 | 0.170 |
Why?
|
Diverticulitis | 1 | 2022 | 177 | 0.170 |
Why?
|
Cholestasis | 1 | 2022 | 375 | 0.170 |
Why?
|
Incidental Findings | 1 | 2024 | 685 | 0.160 |
Why?
|
Radiopharmaceuticals | 2 | 2024 | 2656 | 0.160 |
Why?
|
Living Donors | 1 | 2023 | 612 | 0.160 |
Why?
|
Kidney Diseases | 2 | 2009 | 2074 | 0.160 |
Why?
|
Fever | 2 | 2022 | 1604 | 0.150 |
Why?
|
Neuroendocrine Tumors | 1 | 2024 | 642 | 0.150 |
Why?
|
Fluoroscopy | 1 | 2021 | 939 | 0.150 |
Why?
|
Biopsy, Needle | 1 | 2021 | 1634 | 0.140 |
Why?
|
Ultrasonography | 3 | 2024 | 5903 | 0.130 |
Why?
|
Hypoglycemia | 1 | 2023 | 844 | 0.130 |
Why?
|
Radiology Information Systems | 1 | 2020 | 524 | 0.130 |
Why?
|
Luminol | 1 | 2015 | 6 | 0.130 |
Why?
|
Ammonium Sulfate | 1 | 2015 | 30 | 0.130 |
Why?
|
Appendicitis | 1 | 2022 | 662 | 0.130 |
Why?
|
Halogenation | 1 | 2015 | 51 | 0.130 |
Why?
|
Enzyme Assays | 1 | 2015 | 108 | 0.120 |
Why?
|
Positron-Emission Tomography | 3 | 2023 | 6419 | 0.110 |
Why?
|
Iron | 1 | 2021 | 1737 | 0.110 |
Why?
|
Radiation Dosage | 1 | 2021 | 1950 | 0.110 |
Why?
|
Aromatase | 1 | 2012 | 146 | 0.100 |
Why?
|
Staurosporine | 1 | 2012 | 247 | 0.090 |
Why?
|
Energy Transfer | 1 | 2010 | 108 | 0.090 |
Why?
|
Urea | 2 | 2012 | 435 | 0.090 |
Why?
|
Feces | 19 | 1961 | 1432 | 0.090 |
Why?
|
Pneumonia | 1 | 2021 | 2115 | 0.080 |
Why?
|
Cattle | 1 | 2015 | 3839 | 0.080 |
Why?
|
Oxidation-Reduction | 1 | 2015 | 2187 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2391 | 0.080 |
Why?
|
Radiation, Ionizing | 1 | 2009 | 252 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 4 | 2024 | 35829 | 0.080 |
Why?
|
Aromatase Inhibitors | 1 | 2012 | 509 | 0.080 |
Why?
|
Directed Molecular Evolution | 1 | 2009 | 157 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3790 | 0.070 |
Why?
|
Polymers | 1 | 2015 | 1612 | 0.070 |
Why?
|
Humans | 48 | 2024 | 746897 | 0.070 |
Why?
|
Liver | 1 | 2023 | 7382 | 0.070 |
Why?
|
Thiophenes | 1 | 2012 | 586 | 0.070 |
Why?
|
Antioxidants | 1 | 2015 | 1643 | 0.070 |
Why?
|
Radiology | 1 | 2020 | 2084 | 0.070 |
Why?
|
Fatal Outcome | 2 | 2021 | 1823 | 0.070 |
Why?
|
Tissue Donors | 1 | 2015 | 2211 | 0.060 |
Why?
|
Protein Kinases | 1 | 2012 | 1615 | 0.060 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2009 | 730 | 0.060 |
Why?
|
Gallbladder Diseases | 1 | 2024 | 137 | 0.050 |
Why?
|
Protein Binding | 1 | 2015 | 9290 | 0.050 |
Why?
|
Mice, Nude | 1 | 2009 | 3583 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2012 | 2887 | 0.050 |
Why?
|
Sweating | 1 | 2022 | 154 | 0.050 |
Why?
|
Fluorescent Dyes | 1 | 2009 | 1895 | 0.050 |
Why?
|
Iron Chelating Agents | 1 | 2021 | 137 | 0.050 |
Why?
|
Constriction, Pathologic | 1 | 2024 | 1086 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2784 | 0.050 |
Why?
|
Transferrin | 1 | 2021 | 282 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3614 | 0.040 |
Why?
|
Alkaline Phosphatase | 1 | 2022 | 854 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2021 | 433 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2024 | 78361 | 0.040 |
Why?
|
Genome, Human | 1 | 2012 | 4361 | 0.040 |
Why?
|
Male | 9 | 2024 | 351556 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13224 | 0.040 |
Why?
|
Image Enhancement | 1 | 2009 | 2875 | 0.040 |
Why?
|
Observer Variation | 1 | 2024 | 2577 | 0.040 |
Why?
|
Cough | 1 | 2021 | 585 | 0.040 |
Why?
|
Abdomen | 1 | 2023 | 1104 | 0.040 |
Why?
|
Edema | 1 | 2021 | 756 | 0.040 |
Why?
|
Middle Aged | 6 | 2024 | 214711 | 0.040 |
Why?
|
Escherichia coli | 1 | 2009 | 4168 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19827 | 0.030 |
Why?
|
Leg | 1 | 2021 | 1087 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12842 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 5614 | 0.030 |
Why?
|
Contrast Media | 1 | 2009 | 5255 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2012 | 20775 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2021 | 1275 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3018 | 0.030 |
Why?
|
Animals | 6 | 2015 | 166593 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1520 | 0.030 |
Why?
|
Receptors, Estrogen | 2 | 2012 | 2169 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2708 | 0.030 |
Why?
|
Dyspnea | 1 | 2021 | 1309 | 0.030 |
Why?
|
Calcium | 4 | 2022 | 5654 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2701 | 0.030 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2012 | 57 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2012 | 13581 | 0.030 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2012 | 148 | 0.030 |
Why?
|
Genes, cdc | 1 | 2012 | 115 | 0.020 |
Why?
|
Societies, Medical | 1 | 2024 | 3790 | 0.020 |
Why?
|
Genes, erbB-2 | 1 | 2012 | 162 | 0.020 |
Why?
|
Acute Disease | 1 | 2022 | 7126 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2022 | 3073 | 0.020 |
Why?
|
Lung Diseases | 1 | 2021 | 1903 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2022 | 4513 | 0.020 |
Why?
|
Female | 6 | 2024 | 382617 | 0.020 |
Why?
|
Mice | 4 | 2012 | 80291 | 0.020 |
Why?
|
Androstadienes | 1 | 2012 | 341 | 0.020 |
Why?
|
Luminescence | 1 | 2010 | 129 | 0.020 |
Why?
|
Genes, p53 | 1 | 2012 | 713 | 0.020 |
Why?
|
Radiography | 1 | 2020 | 6950 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2021 | 1902 | 0.020 |
Why?
|
Rec A Recombinases | 1 | 2009 | 48 | 0.020 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2009 | 143 | 0.020 |
Why?
|
Comorbidity | 1 | 2023 | 10378 | 0.020 |
Why?
|
Camptothecin | 1 | 2012 | 591 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3128 | 0.020 |
Why?
|
Disease | 4 | 1962 | 661 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2012 | 612 | 0.020 |
Why?
|
Antibiotics, Antitubercular | 2 | 1961 | 99 | 0.020 |
Why?
|
Dermatologic Agents | 3 | 1961 | 292 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2012 | 1810 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2012 | 1109 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2023 | 57627 | 0.020 |
Why?
|
Nitriles | 1 | 2012 | 948 | 0.020 |
Why?
|
Mice, SCID | 1 | 2012 | 2622 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7281 | 0.020 |
Why?
|
Triazoles | 1 | 2012 | 901 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2012 | 1727 | 0.020 |
Why?
|
Aged | 3 | 2024 | 164472 | 0.020 |
Why?
|
Diarrhea | 3 | 1962 | 1329 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2022 | 15010 | 0.020 |
Why?
|
Exons | 1 | 2012 | 2391 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4565 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2009 | 1554 | 0.020 |
Why?
|
Colonic Diseases | 2 | 1962 | 198 | 0.020 |
Why?
|
Medicare | 1 | 2022 | 6569 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2012 | 3529 | 0.010 |
Why?
|
Cell Cycle | 1 | 2012 | 2917 | 0.010 |
Why?
|
Drug Design | 1 | 2009 | 1056 | 0.010 |
Why?
|
DNA Repair | 1 | 2012 | 2017 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5776 | 0.010 |
Why?
|
Lung | 1 | 2021 | 9914 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8445 | 0.010 |
Why?
|
DNA Damage | 1 | 2012 | 2385 | 0.010 |
Why?
|
Bacteriology | 2 | 1955 | 10 | 0.010 |
Why?
|
Phylogeny | 1 | 2009 | 2735 | 0.010 |
Why?
|
Fecal Impaction | 1 | 1961 | 33 | 0.010 |
Why?
|
Ion Exchange Resins | 1 | 1961 | 7 | 0.010 |
Why?
|
Ion Exchange | 1 | 1961 | 16 | 0.010 |
Why?
|
Infant | 1 | 2023 | 35465 | 0.010 |
Why?
|
Kinetics | 1 | 2009 | 6362 | 0.010 |
Why?
|
Mucins | 3 | 1948 | 568 | 0.010 |
Why?
|
Dysentery, Amebic | 1 | 1960 | 6 | 0.010 |
Why?
|
Dysentery | 1 | 1960 | 14 | 0.010 |
Why?
|
Amoeba | 1 | 1960 | 20 | 0.010 |
Why?
|
Electrolytes | 1 | 1961 | 280 | 0.010 |
Why?
|
Bilirubin | 1 | 1961 | 423 | 0.010 |
Why?
|
Parasitic Diseases | 1 | 1958 | 76 | 0.010 |
Why?
|
Colon | 2 | 1962 | 1770 | 0.010 |
Why?
|
Biliary Tract Diseases | 1 | 1958 | 156 | 0.010 |
Why?
|
Genetic Variation | 1 | 2012 | 6455 | 0.010 |
Why?
|
Mutation | 2 | 2012 | 29643 | 0.010 |
Why?
|
Apoptosis | 1 | 2012 | 9449 | 0.010 |
Why?
|
Intestinal Diseases | 2 | 1954 | 507 | 0.010 |
Why?
|
Albumins | 2 | 1948 | 563 | 0.010 |
Why?
|
Intestines | 3 | 1954 | 1896 | 0.010 |
Why?
|
Catalase | 1 | 1956 | 209 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 16683 | 0.010 |
Why?
|
Blood | 2 | 1948 | 583 | 0.010 |
Why?
|
Fatty Acids | 2 | 1953 | 1777 | 0.010 |
Why?
|
United States | 1 | 2022 | 70460 | 0.010 |
Why?
|
Calcium, Dietary | 2 | 1948 | 516 | 0.010 |
Why?
|
Anti-Infective Agents | 1 | 1961 | 972 | 0.010 |
Why?
|
Urease | 1 | 1952 | 39 | 0.010 |
Why?
|
Sulfates | 1 | 1954 | 376 | 0.010 |
Why?
|
Soaps | 1 | 1952 | 28 | 0.010 |
Why?
|
Colorimetry | 1 | 1952 | 146 | 0.010 |
Why?
|
Amidohydrolases | 1 | 1952 | 168 | 0.010 |
Why?
|
Steatorrhea | 1 | 1950 | 4 | 0.010 |
Why?
|
Fermentation | 1 | 1951 | 145 | 0.010 |
Why?
|
Oxazines | 1 | 1953 | 315 | 0.010 |
Why?
|
Proteins | 2 | 1958 | 6010 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11585 | 0.010 |
Why?
|
Research | 2 | 1950 | 1954 | 0.010 |
Why?
|
Coloring Agents | 1 | 1953 | 555 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1958 | 1172 | 0.010 |
Why?
|
Urine | 1 | 1951 | 354 | 0.010 |
Why?
|
Anti-Bacterial Agents | 2 | 1961 | 7218 | 0.010 |
Why?
|
Body Fluids | 1 | 1951 | 318 | 0.010 |
Why?
|
Adult | 1 | 2024 | 215291 | 0.010 |
Why?
|
Immune System Diseases | 1 | 1951 | 256 | 0.010 |
Why?
|
Boric Acids | 1 | 1948 | 6 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1953 | 1094 | 0.010 |
Why?
|
Globulins | 1 | 1948 | 20 | 0.000 |
Why?
|
Calcium Compounds | 1 | 1948 | 38 | 0.000 |
Why?
|
Yeasts | 1 | 1948 | 282 | 0.000 |
Why?
|
Biochemistry | 1 | 1948 | 114 | 0.000 |
Why?
|
Biometry | 1 | 1950 | 563 | 0.000 |
Why?
|
Colitis | 1 | 1956 | 1211 | 0.000 |
Why?
|
Oxalic Acid | 1 | 1946 | 18 | 0.000 |
Why?
|
Time Factors | 1 | 2009 | 39639 | 0.000 |
Why?
|
Nitrogen | 1 | 1948 | 349 | 0.000 |
Why?
|
Oxalates | 1 | 1946 | 84 | 0.000 |
Why?
|
Vegetables | 1 | 1951 | 1188 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2012 | 63767 | 0.000 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 1945 | 65 | 0.000 |
Why?
|
Bacteremia | 1 | 1951 | 962 | 0.000 |
Why?
|
Thinness | 1 | 1948 | 492 | 0.000 |
Why?
|
Colitis, Ulcerative | 1 | 1956 | 1900 | 0.000 |
Why?
|
Parasites | 1 | 1945 | 162 | 0.000 |
Why?
|
Blood Proteins | 1 | 1946 | 1151 | 0.000 |
Why?
|
Rheumatic Diseases | 1 | 1945 | 622 | 0.000 |
Why?
|
Psoriasis | 1 | 1946 | 908 | 0.000 |
Why?
|
Sepsis | 1 | 1951 | 2585 | 0.000 |
Why?
|
Diet | 1 | 1951 | 7888 | 0.000 |
Why?
|